316 articles in this topic
New immunotherapies and targeted drugs show promise for treating aggressive hepatobiliary cancers through innovative approaches.
New research shows brief fasting periods can boost the effectiveness of cancer immunotherapy by reshaping tumor-fighting immune cells.
Scientists develop innovative immunotherapy that reprograms multiple immune cell types to attack cancer while reducing side effects.
Researchers develop monoclonal antibody that specifically inhibits heparanase, reducing tumor growth and metastasis in multiple cancer types.
Revolutionary AI-powered chip identifies cancer biomarkers in blood with unprecedented accuracy, potentially transforming early detection.
New liquid biopsy technology offers minimally invasive cancer detection using simple blood draws instead of tissue biopsies.
Scientists explore how exosomes in urine samples could revolutionize early cancer detection through simple, non-invasive testing.
Scientists identify protein and metabolic markers in blood that can catch lung cancer in early stages when treatment is most effective.
New liquid biopsy combining DNA methylation and protein markers shows promise for early multi-cancer detection across nine major cancer types.
Combination immunotherapy before surgery achieved 60% four-year survival in liver cancer, with biomarkers predicting response.
New research reveals how gut microbiome restoration could treat inflammatory bowel disease and boost cancer treatments.
Specific bacterial metabolic pathways in the gut determine whether cancer immunotherapy works by controlling immune responses.
